TipRanks
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
US Market
RNAZ
TransCode Therapeutics
RESEARCH TOOLSreports
Want to see RNAZ full AI Analyst Report?

TransCode Therapeutics (RNAZ) Balance Sheet

442 Followers

TransCode Therapeutics Balance Sheet

TransCode Therapeutics's total assets for Q2 2026 were $151.01M, a decrease of -3.92% from the previous quarter. RNAZ total liabilities were $12.65M for the fiscal quarter, a 0.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Mar 24Dec 22Mar 22
Total Assets
$ 162.40M$ 7.29M$ 5.17M$ 7.59M$ 22.94M
Total Liabilities
$ 152.06M$ 9.31M$ 3.53M$ 4.35M$ 2.53M
Total Equity Gross Minority
$ 10.34M$ -2.02M$ 1.64M$ 3.24M$ 20.40M
Other Metrics
Currency in USD

TransCode Therapeutics Debt to Assets